Review period expiry for use of 4-(1,1,3,3-Tetra methylbutyl)phenol, ethoxylated (4-tert-OPnEO)
4th January 2033
4-(1,1,3,3-Tetra methylbutyl)phenol, ethoxylated (4-tert-OPnEO)
- 1 use applied for by Eli Lilly Kinsale Limited
|
Reference of the decision |
Date of decision |
Substance name |
Holder of the authorisation |
Authorisation number |
Authorised use |
Date of expiry of review period |
|
C(2022) 1497 |
16 March 2022 |
4-(1,1,3,3-Tetra methylbutyl)phenol, ethoxylated (4-tert-OPnEO) EC No: -, CAS No:- |
Eli Lilly Kinsale Limited, Dunderrow, Kinsale, P17 NY71 Cork, Co. Cork Ireland |
REACH/22/6/0 |
Industrial use as a patient safety viral inactivation reagent in the manufacture of human medicines produced from biological systems |
4 January 2033 |